New products!
Publication date : 2019-02-06
We are pleased to announce several additons to our extensive Monoclonal Antibody range. Click here to discover more ....
Excellence in monoclonal antibody and immunoassay development
Discover Diaclone
With over 30 years of experience and expertise, high quality has become the hallmark of the Diaclone Immunology products, firmly establishing us as a centre of excellence in Monoclonal Antibody research and Immunoassay Kit development.
The expanding range of Diaclone immunology products is specifically designed to advance research applications.
Our experience and expertise coupled to the diversity and quality of our product range makes Diaclone a clear choice to Fast Track Your Research.
Diaclone is based in Besancon, France and is a member of the Biotech Investissement group of companies who collectively provide an expert synergy in the field of monoclonal antibodies.
Focus on...
- Monoclonal Antibodies
- Antibody
- Biologically Active Antibodies
- Capture Antibody
- Detection Antibody
- Isotype Control
- Multiplex
- DIAplex
- Apoptosis
- B Cell Antigens
- Cancer Marker
- Carbohydrate Markers
- CD Markers
- Cell Adhesion
- Cytokine / Chemokine Receptors
- Cytokine/Chemokine Receptors
- Cytokines / Growth Factors
- Cytotoxic Molecules
- Endothelial Cells
- Epitope Tags
- In-vivo control
- Innate Immunity
- Isotype Controls
- Isoype Control
- Misc
- Myeloid Cells
- NK Cells
- Non Lineage Markers
- Platelets
- Soluble Antigens
- T Cells
- Tetraspanin
- Tumor Cells
- c-Myc
- CD10
- CD102
- CD102 / ICAM-2
- CD105
- CD106
- CD106 / VCAM-1
- CD107a
- CD109
- CD112
- CD116
- CD117
- CD117 / c-kit
- CD11a
- CD11a / LFA-1
- CD11b
- CD11b / MAC-1
- CD11c
- CD11c / Integrin a X
- CD124
- CD126
- CD126 / IL-6R
- CD13
- CD130
- CD130 / gp130
- CD138
- CD138 / Syndecan-1
- CD14
- CD141
- CD141 / Thrombomodulin
- CD146
- CD15
- CD151
- CD151 / TA-3
- CD154
- CD154 / CD40L
- CD16
- CD161
- CD178
- CD178/FAS-L
- CD18
- CD184
- CD19
- CD196
- CD1a
- CD1b/c
- CD2
- CD2 / LFA-2
- CD20
- CD202b / Tie-2 / TEK
- CD21
- CD213a1
- CD213a1 / IL-13Ra1
- CD213a2
- CD213a2 / IL-13Ra2
- CD22
- CD23
- CD25
- CD25 / IL-2R
- CD27
- CD28
- CD29
- CD3
- CD30
- CD31
- CD31 / PECAM-1
- CD33
- CD34 Class I
- CD34 Class I
- CD34 Class III
- CD35
- CD36
- CD4
- CD40
- CD40L
- CD41
- CD41a
- CD41a / GPIIIb
- CD42b
- CD42b / GPIb
- CD43
- CD44
- CD44 / PGP-1
- CD45
- CD45RA
- CD45RO
- CD48
- CD48 / BLAST-1
- CD49d
- CD5
- CD50
- CD53
- CD54
- CD54 / ICAM-1
- CD55
- CD56
- CD56 / NCAM
- CD57
- CD58
- CD59
- CD6
- CD61
- CD61 / GPIIIa
- CD62E
- CD62E / E-Selectin
- CD62L
- CD62L / L-Selectin
- CD62P
- CD62P / P-Selectin
- CD63
- CD66a
- CD7
- CD71
- CD75
- CD8
- CD80
- CD80 / B7 / BB1
- CD81
- CD82
- CD86
- CD9
- CD94
- CD95
- CD95 / FAS
- CD99
- Cytochrome C
- IFN alpha 2a
- IFN gamma
- IFN-γ
- IL-10
- IL-12
- IL-12p35+p70
- IL-12p40
- IL-12p40+p70
- IL-12p70
- IL-13
- IL-15
- IL-17A
- IL-17A/F
- IL-17F
- IL-18Ra
- IL-18Rb
- IL-1α
- IL-1β
- IL-2
- IL-21
- IL-22
- IL-23
- IL-23 p19
- IL-24
- IL-24 / MDA-7 / Th2-specific cytokine FISP
- IL-27
- IL-29
- IL-31
- IL-32
- IL-33
- IL-34
- IL-35
- IL-37
- IL-4
- IL-5
- IL-6
- IL-7
- IL-8
- IP-10
- Isotype Control
QVQ joins the Biotech Investissement Group
Publication date : 2018-10-12
We are pleased to announce that QVQ, a company based in Utrecht (The Netherlands), is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA (Biotech Investissement Group – www.mabexperts.com).